Oragenics (OGEN) Short Interest Ratio & Short Volume $1.32 +0.06 (+4.76%) Closing price 04:00 PM EasternExtended Trading$1.30 -0.02 (-1.59%) As of 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Oragenics Short Interest DataOragenics (OGEN) has a short interest of 68,000 shares, representing 9.88% of the float (the number of shares available for trading by the public). This marks a -78.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 344,209 shares to cover all short positions.Current Short Interest68,000 sharesPrevious Short Interest313,800 sharesChange Vs. Previous Month-78.33%Dollar Volume Sold Short$91.12 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares823,000 sharesFloat Size688,300 sharesShort Percent of Float9.88%Today's Trading Volume99,219 sharesAverage Trading Volume344,209 sharesToday's Volume Vs. Average29% Short Selling Oragenics? Sign up to receive the latest short interest report for Oragenics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOGEN Short Interest Over TimeOGEN Days to Cover Over TimeOGEN Percentage of Float Shorted Over Time Oragenics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202568,000 shares $91.12 thousand -78.3%9.9%0.1 $1.34 6/30/2025313,800 shares $1.20 million +8.4%45.6%0.6 $3.82 6/15/2025289,500 shares $1.26 million +258.7%43.0%1.4 $4.36 5/31/202580,700 shares $290.52 thousand -91.0%12.0%0.4 $3.60 5/15/2025891,300 shares $173.45 thousand +29.3%4.4%2.4 $0.19 4/30/2025689,300 shares $128.07 thousand +33.7%3.4%1.1 $0.19 4/15/2025515,600 shares $96.06 thousand +279.1%3.0%0.1 $0.19 3/14/2025312,600 shares $87.53 thousand -20.4%1.8%0.1 $0.28 2/14/20251,480,000 shares $441.04 thousand -30.5%14.8%0.3 $0.30 1/31/20252,130,000 shares $658.17 thousand +56.6%21.3%0.4 $0.31 Get the Latest News and Ratings for OGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20251,360,000 shares $414.12 thousand +114.3%13.6%1.6 $0.30 1/31/202454,000 shares $0.00 +64.6%2.1%1.8 $0.00 1/15/202432,800 shares $0.00 +20.2%1.3%3 $0.00 12/31/202327,300 shares $0.00 -10.8%1.3%2.4 $0.00 12/15/202330,600 shares $0.00 -24.6%1.4%1.6 $0.00 11/30/202340,600 shares $0.00 -11.4%1.9%2.4 $0.00 11/15/202345,800 shares $0.00 -12.6%2.1%2.8 $0.00 10/31/202352,400 shares $0.00 -25.9%2.5%3 $0.00 10/15/202370,700 shares $0.00 +272.1%3.5%3.8 $0.00 9/30/202319,000 shares $0.00 +20.3%0.8%0.9 $0.00 9/15/202315,800 shares $0.00 -41.7%0.7%1.5 $0.00 8/31/202327,100 shares $0.00 +15.8%1.2%2.6 $0.00 8/15/202323,400 shares $71.14 thousand -23.8%1.0%2.3 $3.04 7/31/202330,700 shares $119.73 thousand -31.0%1.5%2.6 $3.90 7/15/202344,500 shares $164.43 thousand +7.2%2.2%4.3 $3.70 6/30/202341,500 shares $137.28 thousand +2.5%2.1%4.8 $3.31 6/15/202340,500 shares $119.07 thousand -10.2%2.0%3.7 $2.94 5/31/202345,100 shares $134.40 thousand +15.4%2.3%3.2 $2.98 5/15/202339,100 shares $0.00 -15.2%2.0%2.4 $0.00 4/30/202346,100 shares $0.00 -8.0%2.3%3 $0.00 4/15/202350,100 shares $157.31 thousand -6.0%2.5%2.3 $3.14 3/31/202353,300 shares $0.00 +8.8%2.8%2.3 $0.00 3/15/202349,000 shares $0.00 +84.9%2.6%1.8 $0.00 2/28/202326,500 shares $0.00 -8.3%1.4%1.1 $0.00 2/15/202328,900 shares $0.00 -3.3%1.5%1.3 $0.00 1/31/202329,900 shares $0.00 -3.6%1.6%1.4 $0.00 1/15/202331,000 shares $0.00 -98.1%N/A1.7 $0.00 12/30/20221,630,000 shares $0.00 +5.8%1.4%2.2 $0.00 12/15/20221,540,000 shares $0.00 -12.0%1.3%2.7 $0.00 11/30/20221,750,000 shares $0.00 +13.6%1.5%5.9 $0.00Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.Watch Alex's "Next Magnificent Seven" presentation now. 11/15/20221,540,000 shares $0.00 -5.5%1.4%5.3 $0.00 10/31/20221,630,000 shares $0.00 +3.8%1.4%5.8 $0.00 10/15/20221,570,000 shares $0.00 -2.5%1.4%5.7 $0.00 9/30/20221,610,000 shares $365.47 thousand -1.2%1.4%6.3 $0.23 9/15/20221,630,000 shares $0.00 -3.6%1.4%6.3 $0.00 8/31/20221,690,000 shares $0.00 +27.1%1.5%6.2 $0.00 8/15/20221,330,000 shares $0.00 -30.4%1.2%4.4 $0.00 7/31/20221,910,000 shares $0.00 -8.6%1.7%5.3 $0.00 7/15/20222,090,000 shares $0.00 -10.3%1.9%5.6 $0.00 6/30/20222,330,000 shares $0.00 -2.1%2.1%5.7 $0.00 6/15/20222,380,000 shares $0.00 -14.7%2.1%4.1 $0.00 5/31/20222,790,000 shares $0.00 +34.1%2.5%4.3 $0.00 5/15/20222,080,000 shares $0.00 -32.3%1.8%2.8 $0.00 4/30/20223,070,000 shares $0.00 No Change2.7%3.9 $0.00 4/15/20223,070,000 shares $0.00 +3.7%2.7%3.7 $0.00 3/31/20222,960,000 shares $1.02 million -10.8%2.6%3.1 $0.34 3/15/20223,320,000 shares $0.00 +37.2%2.9%2 $0.00 2/28/20222,420,000 shares $899.27 thousand -27.5%2.1%1.4 $0.37 2/15/20223,340,000 shares $0.00 +2.5%2.9%1.7 $0.00 1/31/20223,260,000 shares $1.38 million -1.8%2.9%1.6 $0.42 1/15/20223,320,000 shares $0.00 -2.1%2.9%1 $0.00 12/31/20213,390,000 shares $1.51 million +53.4%3.0%1 $0.45 12/15/20212,210,000 shares $0.00 -25.3%1.9%0.7 $0.00 11/30/20212,960,000 shares $0.00 -13.7%2.6%1.1 $0.00 11/15/20213,430,000 shares $0.00 +22.1%3.0%1.3 $0.00 10/29/20212,810,000 shares $1.80 million +17.1%2.5%1 $0.64 10/15/20212,400,000 shares $0.00 -10.5%2.1%0.4 $0.00 9/30/20212,680,000 shares $0.00 +0.4%2.3%0.5 $0.00 9/15/20212,670,000 shares $0.00 +25.4%2.3%0.5 $0.00 8/31/20212,130,000 shares $0.00 -41.3%1.9%0.4 $0.00 8/13/20213,630,000 shares $0.00 -37.1%3.2%0.6 $0.00 7/30/20215,770,000 shares $0.00 +112.1%5.1%0.9 $0.00 7/15/20212,720,000 shares $0.00 No Change2.4%1 $0.00 6/30/20212,720,000 shares $0.00 -4.9%2.4%1 $0.00 6/15/20212,860,000 shares $0.00 +10.4%2.5%1 $0.00 5/28/20212,590,000 shares $0.00 -1.2%2.3%0.7 $0.00 5/14/20212,620,000 shares $0.00 -10.9%N/A0.4 $0.00 4/30/20212,940,000 shares $0.00 +4.6%N/A0.3 $0.00 4/15/20212,810,000 shares $1.94 million -2.1%N/A0.2 $0.69 3/31/20212,870,000 shares $2.41 million -18.9%N/A0.1 $0.84 3/15/20213,540,000 shares $2.76 million +39.4%N/A0.1 $0.78 2/26/20212,540,000 shares $2.06 million -22.6%N/A0.1 $0.81 2/12/20213,280,000 shares $4.10 million -2.1%N/A0.1 $1.25 1/29/20213,350,000 shares $3.89 million -23.2%N/A0.1 $1.16 1/15/20214,360,000 shares $6.63 million +108.6%N/A0.2 $1.52 12/31/20202,090,000 shares $911.87 thousand +53.7%N/A0.2 $0.44 12/15/20201,360,000 shares $588.88 thousand -7.5%N/A0.2 $0.43 11/30/20201,470,000 shares $609.90 thousand -17.0%N/A0.3 $0.41 11/15/20201,770,000 shares $838.98 thousand +65.4%N/A0.7 $0.47 10/30/20201,070,000 shares $555.97 thousand -19.6%N/A0.4 $0.52Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.Watch Alex's "Next Magnificent Seven" presentation now. 10/15/20201,330,000 shares $776.72 thousand -14.2%N/A0.4 $0.58 9/30/20201,550,000 shares $891.25 thousand -32.9%3.4%0.2 $0.58 9/15/20202,310,000 shares $1.73 million -1.3%5.1%0.3 $0.75 8/31/20202,340,000 shares $1.71 million +46.3%5.2%0.3 $0.73 8/14/20201,600,000 shares $1.45 million -59.7%3.7%0.2 $0.91 OGEN Short Interest - Frequently Asked Questions What is Oragenics' current short interest? Short interest is the volume of Oragenics shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 68,000 shares of OGEN short. 9.88% of Oragenics' shares are currently sold short. Learn More on Oragenics' current short interest. What is a good short interest percentage for Oragenics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.88% of Oragenics' floating shares are currently sold short. Is Oragenics' short interest increasing or decreasing? Oragenics saw a decrease in short interest in July. As of July 15th, there was short interest totaling 68,000 shares, a decrease of 78.3% from the previous total of 313,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Oragenics' float size? Oragenics currently has issued a total of 823,000 shares. Some of Oragenics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oragenics currently has a public float of 688,300 shares. How does Oragenics' short interest compare to its competitors? 9.88% of Oragenics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Oragenics: Orgenesis Inc. (0.17%), Clearmind Medicine Inc. (17.95%), Qualigen Therapeutics, Inc. (1.64%), Soligenix Inc. (8.91%), Avalon GloboCare Corp. (36.90%), Dermata Therapeutics, Inc. (2.01%), Evaxion A/S - Sponsored ADR (9.25%), Virax Biolabs Group Limited (0.57%), Revelation Biosciences, Inc. (13.70%), Tharimmune, Inc. (0.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Oragenics stock? Short selling OGEN is an investing strategy that aims to generate trading profit from Oragenics as its price is falling. OGEN shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Oragenics? A short squeeze for Oragenics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OGEN, which in turn drives the price of the stock up even further. How often is Oragenics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OGEN, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Orgenesis Short Interest Data Clearmind Medicine Short Interest Data Qualigen Therapeutics Short Interest Data Soligenix Short Interest Data Avalon GloboCare Short Interest Data Dermata Therapeutics Short Interest Data Evaxion A/S Short Interest Data Virax Biolabs Group Short Interest Data Revelation Biosciences Short Interest Data Tharimmune Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:OGEN) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.